Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02324907 · ClinicalTrials.gov registry record
The Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 39
- Enrollment target
NCT02324907: Completed study, sponsored by Duke University.
NCT02324907 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02324907 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical efficacy of a novel dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis.
Primary Outcome
Visual Analog Scale (VAS)
Interventions
- DEVICE Procedure/Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2015-01-28 |
| Est. Completion | 2023-01-09 |
What the finished NCT02324907 record still lists
NCT02324907 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Procedure/Surgery is the first listed.
NCT02324907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02324907 about?
NCT02324907 is a clinical study titled "The Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis". The purpose of this study is to determine the clinical efficacy of a novel dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis.
What is the current status of trial NCT02324907?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2015-01-28. Estimated completion is 2023-01-09.
What interventions are being tested in trial NCT02324907?
The interventions under investigation include: Procedure/Surgery (DEVICE).
Who is sponsoring clinical trial NCT02324907?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI